Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Asthma | R-HSA-444620 | map05310 | ciclacillin | 71415 | drug-path |
Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | ciclacillin | 71415 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | ciclacillin | 71415 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | ciclacillin | 71415 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | ciclacillin | 71415 | drug-path |
Notch signaling pathway | R-HSA-157118 | map04330 | ciclacillin | 71415 | drug-path |
Gap junction | R-HSA-190861 | map04540 | ciclacillin | 71415 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | ciclacillin | 71415 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | flutamide | 3397 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | flutamide | 3397 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | flutamide | 3397 | drug-path |
Bladder cancer | R-HSA-9700206 | map05219 | flutamide | 3397 | drug-path |
Renal cell carcinoma | R-HSA-9794523 | map05211 | flutamide | 3397 | drug-path |
B cell receptor signaling pathway | R-HSA-983705 | map04662 | flutamide | 3397 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | flutamide | 3397 | drug-path |
Pathways in cancer | R-HSA-9824443 | map05200 | flutamide | 3397 | drug-path |
Acute myeloid leukemia | R-HSA-9680350 | map05221 | flutamide | 3397 | drug-path |
VEGF signaling pathway | R-HSA-194138 | map04370 | flutamide | 3397 | drug-path |
Thyroid cancer | R-HSA-9700206 | map05216 | flutamide | 3397 | drug-path |
Non-small cell lung cancer | R-HSA-5619066 | map05223 | flutamide | 3397 | drug-path |